Lista de obras - E Maiello - Dominio Público Uruguay

5-Fluorouracil and folinic acid with or without CPT-11 in advanced colorectal cancer patients: a multicenter randomised phase II study of the Southern Italy Oncology Group

scientific article published on 01 August 2000

A miRNA signature for defining aggressive phenotype and prognosis in gliomas

artículo científico publicado en 2014

A prospective study on survival in cancer patients with and without venous thromboembolism

artículo científico publicado en 2013

A prothrombotic state in breast cancer patients treated with adjuvant chemotherapy

artículo científico publicado en 1996

ALK and NRG1 Fusions Coexist in a Patient with Signet Ring Cell Lung Adenocarcinoma

artículo científico publicado en 2017

ASCEND-8: A Randomized Phase 1 Study of Ceritinib, 450 mg or 600 mg, Taken with a Low-Fat Meal versus 750 mg in Fasted State in Patients with Anaplastic Lymphoma Kinase (ALK)-Rearranged Metastatic Non-Small Cell Lung Cancer (NSCLC).

artículo científico publicado en 2017

AVAREG: a phase II, randomized, noncomparative study of fotemustine or bevacizumab for patients with recurrent glioblastoma

artículo científico publicado en 2016

Aberrant genes promoter methylation in neural crest-derived tumors

article

Adherence to AIOM (Italian Association of Medical Oncology) lung cancer guidelines in Italian clinical practice: Results from the RIGHT-3 (research for the identification of the most effective and highly accepted clinical guidelines for cancer treat

artículo científico publicado en 2015

Adjuvant chemotherapy with epirubicin, leucovorin, 5-fluorouracil and etoposide regimen in resected gastric cancer patients: a randomized phase III trial by the Gruppo Oncologico Italia Meridionale (GOIM 9602 Study)

artículo científico publicado en 2007

Adjuvant colon cancer chemotherapy: where we are and where we'll go.

artículo científico publicado en 2010

Adjuvant therapy in colon cancer.

artículo científico publicado en 2009

Aflibercept Plus FOLFIRI in the Real-life Setting: Safety and Quality of Life Data From the Italian Patient Cohort of the Aflibercept Safety and Quality-of-Life Program Study.

artículo científico publicado en 2018

Agreement between oncology guidelines and clinical practice in Italy: the 'right' program. A project of the Italian Association of Medical Oncology (AIOM)

article

Alexithymia and cancer pain: the effect of psychological intervention.

artículo científico publicado en 2010

Alexithymia, coping, and illness behavior correlates of pain experience in cancer patients

artículo científico publicado en 2007

An Italian cost-effectiveness analysis of paclitaxel albumin (nab-paclitaxel) + gemcitabine vs gemcitabine alone for metastatic pancreatic cancer patients: the APICE study.

artículo científico publicado en 2018

BRAF V600E mutation in metastatic colorectal cancer: Methods of detection and correlation with clinical and pathologic features.

artículo científico publicado en 2016

Basal and bevacizumab-based therapy-induced changes of lactate dehydrogenases and fibrinogen levels and clinical outcome of previously untreated metastatic colorectal cancer patients: a multicentric retrospective analysis.

artículo científico publicado en 2014

Biological characterization and selection criteria of adjuvant chemotherapy for early breast cancer: experience from the Italian observational NEMESI study

artículo científico publicado en 2012

Biweekly combination of trastuzumab, docetaxel and gemcitabine for HER2-positive metastatic breast cancer: results of a Phase II GOIM study

artículo científico publicado en 2014

Bone metastases in patients with metastatic renal cell carcinoma: are they always associated with poor prognosis?

artículo científico publicado en 2015

CDC73 mutations and parafibromin immunohistochemistry in parathyroid tumors: clinical correlations in a single-centre patient cohort

article by Vito Guarnieri et al published 18 September 2012 in Cellular Oncology

CES2, ABCG2, TS and Topo-I primary and synchronous metastasis expression and clinical outcome in metastatic colorectal cancer patients treated with first-line FOLFIRI regimen

artículo científico publicado en 2014

Cetuximab continuation after first progression in metastatic colorectal cancer (CAPRI-GOIM): a randomized phase II trial of FOLFOX plus cetuximab versus FOLFOX.

artículo científico publicado en 2016

Cetuximab in squamous cell head and neck carcinomas.

artículo científico publicado en 2007

Cetuximab plus FOLFOX-4 in untreated patients with advanced colorectal cancer: a Gruppo Oncologico dell'Italia Meridionale Multicenter phase II study

artículo científico publicado en 2010

Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance?

artículo científico publicado en 2017

Cetuximab: clinical results in colorectal cancer.

artículo científico publicado en 2007

Changes in CpG islands promoter methylation patterns during ductal breast carcinoma progression

artículo científico publicado en 2009

Changes in miR-143 and miR-21 expression and clinicopathological correlations in pancreatic cancers.

artículo científico publicado en 2012

Chemokine receptor CXCR4: role in gastrointestinal cancer.

artículo científico publicado en 2013

Cisplatin/Pemetrexed Followed by Maintenance Pemetrexed Versus Carboplatin/Paclitaxel/Bevacizumab Followed by Maintenance Bevacizumab in Advanced Nonsquamous Lung Cancer: The GOIM (Gruppo Oncologico Italia Meridionale) ERACLE Phase III Randomized Tr

artículo científico publicado en 2014

Clinic, Endoscopic and Histological Features in Patients Treated with ICI Developing GI Toxicity: Some News and Reappraisal from a Mono-Institutional Experience

artículo científico publicado en 2022

Clinical activity of FOLFIRI plus cetuximab according to extended gene mutation status by next-generation sequencing: findings from the CAPRI-GOIM trial.

artículo científico publicado en 2014

Common germline variants within the CDKN2A/2B region affect risk of pancreatic neuroendocrine tumors

artículo científico publicado en 2016

Comparison of CHOP-B vs CEOP-B in 'poor prognosis' non-Hodgkin's lymphomas. A randomized trial.

artículo científico publicado en 1989

Competitive allele-specific TaqMan PCR (Cast-PCR) is a sensitive, specific and fast method for BRAF V600 mutation detection in Melanoma patients

artículo científico publicado en 2015

Dose intensity and efficacy of the combination of everolimus and exemestane (EVE/EXE) in a real-world population of hormone receptor-positive (ER+/PgR+), HER2-negative advanced breast cancer (ABC) patients: a multicenter Italian experience.

artículo científico publicado en 2017

Efficacy and Safety of Bevacizumab Combined With Fluoropyrimidine Monotherapy for Unfit or Older Patients With Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis

artículo científico publicado en 2016

Efficacy and safety of cetuximab/irinotecan in chemotherapy-refractory metastatic colorectal adenocarcinomas: a clinical practice setting, multicenter experience

artículo científico publicado en 2006

Epidoxorubicin and double biochemical 5-fluorouracil modulation with folinic acid and human lymphoblastoid interferon in advanced gastric carcinoma: a multicentric phase II study of the Southern Italy Oncology Group (GOIM)

scientific article published on 01 July 1996

Epirubicin, folinic acid, fluorouracil, and etoposide in the treatment of advanced gastric cancer: phase II study of the Southern Italy Oncology Group (GOIM)

scientific article published on 01 June 1999

Evaluation of microRNA-10b prognostic significance in a prospective cohort of breast cancer patients.

artículo científico publicado en 2014

Evidence-based guidelines: Improving AGREEment on consistence evaluation

artículo científico publicado en 2012

FOLFIRI regimen in advanced colorectal cancer: the experience of the Gruppo Oncologico dell'Italia Meridionale (GOIM).

artículo científico publicado en 2005

FOLFIRI with or without celecoxib in advanced colorectal cancer: a randomized phase II study of the Gruppo Oncologico dell'Italia Meridionale (GOIM)

artículo científico publicado en 2006

Frequent NRG1 fusions in Caucasian pulmonary mucinous adenocarcinoma predicted by Phospho-ErbB3 expression.

artículo científico publicado en 2018

Frequent epigenetics inactivation of KEAP1 gene in non-small cell lung cancer

artículo científico publicado en 2011

Gemcitabine and cisplatin for inoperable and/or metastatic biliary tree carcinomas: a multicenter phase II study of the Gruppo Oncologico dell'Italia Meridionale (GOIM).

artículo científico publicado en 2006

Gene expression of somatostatin receptor subtypes SSTR2a, SSTR3 and SSTR5 in peripheral blood of neuroendocrine lung cancer affected patients.

artículo científico publicado en 2011

Genomic instability and increased expression of BUB1B and MAD2L1 genes in ductal breast carcinoma

article

Heterogeneity of KRAS, NRAS, BRAF and PIK3CA mutations in metastatic colorectal cancer and potential effects on therapy in the CAPRI GOIM trial.

artículo científico publicado en 2015

High RAD51 mRNA expression characterize estrogen receptor-positive/progesteron receptor-negative breast cancer and is associated with patient's outcome

artículo científico publicado en 2011

High specificity of quantitative methylation-specific PCR analysis for MGMT promoter hypermethylation detection in gliomas

artículo científico publicado en 2009

Irinotecan plus bolus/infusional 5-Fluorouracil and leucovorin in patients with pretreated advanced pancreatic carcinoma: a multicenter experience of the Gruppo Oncologico Italia Meridionale.

artículo científico publicado en 2010

KRAS mutations and sensitivity to anti-EGFR monoclonal antibodies in metastatic colorectal carcinoma: an open issue

artículo científico publicado en 2009

Liposomal-encapsulated doxorubicin plus cyclophosphamide as first-line therapy in metastatic breast cancer: a phase II multicentric study

artículo científico publicado en 2007

MEN1 gene mutation with parathyroid carcinoma: first report of a familial case.

artículo científico publicado en 2017

Management of Skin Reactions During Cetuximab Treatment in Association With Chemotherapy or Radiotherapy: Update of the Italian Expert Recommendations

artículo científico publicado en 2016

Management of skin toxicity associated with cetuximab treatment in combination with chemotherapy or radiotherapy

artículo científico publicado en 2011

MicroRNA co-expression networks exhibit increased complexity in pancreatic ductal compared to Vater's papilla adenocarcinoma.

artículo científico publicado en 2017

Modeling interactions between Human Equilibrative Nucleoside Transporter-1 and other factors involved in the response to gemcitabine treatment to predict clinical outcomes in pancreatic ductal adenocarcinoma patients.

artículo científico publicado en 2014

Molecular profiling in Italian patients with advanced non-small-cell lung cancer: An observational prospective study.

artículo científico publicado en 2017

Molecularly targeted endocrine therapies for breast cancer.

artículo científico publicado en 2010

Natural history of bone metastasis in colorectal cancer: final results of a large Italian bone metastases study

artículo científico publicado en 2012

Natural history of malignant bone disease in gastric cancer: final results of a multicenter bone metastasis survey

artículo científico publicado en 2013

Natural history of malignant bone disease in hepatocellular carcinoma: final results of a multicenter bone metastasis survey.

artículo científico publicado en 2014

Natural history of malignant bone disease in renal cancer: final results of an Italian bone metastasis survey

artículo científico publicado en 2013

New molecular targets in bone metastases.

artículo científico publicado en 2010

Non-pegylated liposome-encapsulated doxorubicin citrate plus cyclophosphamide or vinorelbine in metastatic breast cancer not previously treated with chemotherapy:a multicenter phase III study

artículo científico publicado en 2014

Novel association of MEN1 gene mutations with parathyroid carcinoma.

artículo científico publicado en 2017

Optimized granulocyte colony-stimulating factor prophylaxis in adult cancer patients: from biological principles to clinical guidelines.

artículo científico

Pharmacokinetic drug evaluation of osimertinib for the treatment of non-small cell lung cancer.

artículo científico publicado en 2017

Phase II study of panitumumab, oxaliplatin, 5-fluorouracil, and concurrent radiotherapy as preoperative treatment in high-risk locally advanced rectal cancer patients (StarPan/STAR-02 Study).

artículo científico publicado en 2011

Phase III randomized trial of FOLFIRI versus FOLFOX4 in the treatment of advanced colorectal cancer: a multicenter study of the Gruppo Oncologico Dell'Italia Meridionale

artículo científico publicado en 2005

Phase III trial comparing 3-6 months of adjuvant FOLFOX4/XELOX in stage II-III colon cancer: safety and compliance in the TOSCA trial

artículo científico publicado en 2017

Phosphatidylinositol 3-kinase (PI3Kα)/AKT axis blockade with taselisib or ipatasertib enhances the efficacy of anti-microtubule drugs in human breast cancer cells.

artículo científico publicado en 2017

Postchemotherapy residual masses in germ cell tumor patients: our experience

artículo científico publicado en 2006

Prolonged exposure to tyrosine kinase inhibitors or early use of everolimus in metastatic renal cell carcinoma: are the two options alike?

artículo científico publicado en 2013

RAS testing of liquid biopsy correlates with the outcome of metastatic colorectal cancer patients treated with first-line FOLFIRI plus cetuximab in the CAPRI-GOIM trial.

artículo científico publicado en 2017

Randomized phase III trial of gemcitabine plus cisplatin compared with single-agent gemcitabine as first-line treatment of patients with advanced pancreatic cancer: the GIP-1 study

artículo científico publicado en 2010

Relevance of cell kinetics to hormonal response of receptor-positive advanced breast cancer

artículo científico publicado en 1988

Role of external radiation therapy in urinary cancers

artículo científico publicado en 2007

Role of primary miRNA polymorphic variants in metastatic colon cancer patients treated with 5-fluorouracil and irinotecan

scientific article published on 29 June 2010

Second-line chemotherapy in advanced pancreatic carcinoma: a multicenter survey of the Gruppo Oncologico Italia Meridionale on the activity and safety of the FOLFOX4 regimen in clinical practice

artículo científico publicado en 2007

Sequential treatment with high-dose methotrexate and fluorouracil in advanced colorectal cancer. Experience of the Southern Italian Oncology Group (GOIM)

scientific article published on 01 April 1994

Sequential use of sorafenib and sunitinib in advanced renal cell carcinoma: does the order of sequencing matter?

artículo científico publicado en 2011

Stepwise analysis of MIR9 loci identifies miR-9-5p to be involved in Oestrogen regulated pathways in breast cancer patients

artículo científico publicado en 2017

Target therapies in pancreatic carcinoma.

artículo científico

Targeting EGFR in bilio-pancreatic and liver carcinoma

artículo científico publicado en 2011

Temporal stability of alexithymia in cancer patients following a psychological intervention.

artículo científico publicado en 2011

The dark side of the moon: the PI3K/PTEN/AKT pathway in colorectal carcinoma

artículo científico publicado en 2009

The potential role of nintedanib in treating colorectal cancer.

artículo científico publicado en 2017

Total and not bevacizumab-bound vascular endothelial growth factor as potential predictive factors to bevacizumab-based chemotherapy in colorectal cancer

artículo científico publicado en 2016

Treatment of inoperable and/or metastatic biliary tree carcinomas with single-agent gemcitabine or in combination with levofolinic acid and infusional fluorouracil: results of a multicenter phase II study.

artículo científico publicado en 2001

Unusual gastrointestinal and cutaneous toxicities by bleomycin, etoposide, and cisplatin: a case report with pharmacogenetic analysis to personalize treatment.

artículo científico publicado en 2017

Update on capecitabine alone and in combination regimens in colorectal cancer patients

artículo científico publicado en 2010

miR-192/miR-215 influence 5-fluorouracil resistance through cell cycle-mediated mechanisms complementary to its post-transcriptional thymidilate synthase regulation.

artículo científico publicado en 2010

Lista de obras de E Maiello

5-Fluorouracil and folinic acid with or without CPT-11 in advanced colorectal cancer patients: a multicenter randomised phase II study of the Southern Italy Oncology Group

A miRNA signature for defining aggressive phenotype and prognosis in gliomas

A prospective study on survival in cancer patients with and without venous thromboembolism

A prothrombotic state in breast cancer patients treated with adjuvant chemotherapy

ALK and NRG1 Fusions Coexist in a Patient with Signet Ring Cell Lung Adenocarcinoma

ASCEND-8: A Randomized Phase 1 Study of Ceritinib, 450 mg or 600 mg, Taken with a Low-Fat Meal versus 750 mg in Fasted State in Patients with Anaplastic Lymphoma Kinase (ALK)-Rearranged Metastatic Non-Small Cell Lung Cancer (NSCLC).

AVAREG: a phase II, randomized, noncomparative study of fotemustine or bevacizumab for patients with recurrent glioblastoma

Aberrant genes promoter methylation in neural crest-derived tumors

Adherence to AIOM (Italian Association of Medical Oncology) lung cancer guidelines in Italian clinical practice: Results from the RIGHT-3 (research for the identification of the most effective and highly accepted clinical guidelines for cancer treat

Adjuvant chemotherapy with epirubicin, leucovorin, 5-fluorouracil and etoposide regimen in resected gastric cancer patients: a randomized phase III trial by the Gruppo Oncologico Italia Meridionale (GOIM 9602 Study)

Adjuvant colon cancer chemotherapy: where we are and where we'll go.

Adjuvant therapy in colon cancer.

Aflibercept Plus FOLFIRI in the Real-life Setting: Safety and Quality of Life Data From the Italian Patient Cohort of the Aflibercept Safety and Quality-of-Life Program Study.

Agreement between oncology guidelines and clinical practice in Italy: the 'right' program. A project of the Italian Association of Medical Oncology (AIOM)

Alexithymia and cancer pain: the effect of psychological intervention.

Alexithymia, coping, and illness behavior correlates of pain experience in cancer patients

An Italian cost-effectiveness analysis of paclitaxel albumin (nab-paclitaxel) + gemcitabine vs gemcitabine alone for metastatic pancreatic cancer patients: the APICE study.

BRAF V600E mutation in metastatic colorectal cancer: Methods of detection and correlation with clinical and pathologic features.

Basal and bevacizumab-based therapy-induced changes of lactate dehydrogenases and fibrinogen levels and clinical outcome of previously untreated metastatic colorectal cancer patients: a multicentric retrospective analysis.

Biological characterization and selection criteria of adjuvant chemotherapy for early breast cancer: experience from the Italian observational NEMESI study

Biweekly combination of trastuzumab, docetaxel and gemcitabine for HER2-positive metastatic breast cancer: results of a Phase II GOIM study

Bone metastases in patients with metastatic renal cell carcinoma: are they always associated with poor prognosis?

CDC73 mutations and parafibromin immunohistochemistry in parathyroid tumors: clinical correlations in a single-centre patient cohort

CES2, ABCG2, TS and Topo-I primary and synchronous metastasis expression and clinical outcome in metastatic colorectal cancer patients treated with first-line FOLFIRI regimen

Cetuximab continuation after first progression in metastatic colorectal cancer (CAPRI-GOIM): a randomized phase II trial of FOLFOX plus cetuximab versus FOLFOX.

Cetuximab in squamous cell head and neck carcinomas.

Cetuximab plus FOLFOX-4 in untreated patients with advanced colorectal cancer: a Gruppo Oncologico dell'Italia Meridionale Multicenter phase II study

Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance?

Cetuximab: clinical results in colorectal cancer.

Changes in CpG islands promoter methylation patterns during ductal breast carcinoma progression

Changes in miR-143 and miR-21 expression and clinicopathological correlations in pancreatic cancers.

Chemokine receptor CXCR4: role in gastrointestinal cancer.

Cisplatin/Pemetrexed Followed by Maintenance Pemetrexed Versus Carboplatin/Paclitaxel/Bevacizumab Followed by Maintenance Bevacizumab in Advanced Nonsquamous Lung Cancer: The GOIM (Gruppo Oncologico Italia Meridionale) ERACLE Phase III Randomized Tr

Clinic, Endoscopic and Histological Features in Patients Treated with ICI Developing GI Toxicity: Some News and Reappraisal from a Mono-Institutional Experience

Clinical activity of FOLFIRI plus cetuximab according to extended gene mutation status by next-generation sequencing: findings from the CAPRI-GOIM trial.

Common germline variants within the CDKN2A/2B region affect risk of pancreatic neuroendocrine tumors

Comparison of CHOP-B vs CEOP-B in 'poor prognosis' non-Hodgkin's lymphomas. A randomized trial.

Competitive allele-specific TaqMan PCR (Cast-PCR) is a sensitive, specific and fast method for BRAF V600 mutation detection in Melanoma patients

Dose intensity and efficacy of the combination of everolimus and exemestane (EVE/EXE) in a real-world population of hormone receptor-positive (ER+/PgR+), HER2-negative advanced breast cancer (ABC) patients: a multicenter Italian experience.

Efficacy and Safety of Bevacizumab Combined With Fluoropyrimidine Monotherapy for Unfit or Older Patients With Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis

Efficacy and safety of cetuximab/irinotecan in chemotherapy-refractory metastatic colorectal adenocarcinomas: a clinical practice setting, multicenter experience

Epidoxorubicin and double biochemical 5-fluorouracil modulation with folinic acid and human lymphoblastoid interferon in advanced gastric carcinoma: a multicentric phase II study of the Southern Italy Oncology Group (GOIM)

Epirubicin, folinic acid, fluorouracil, and etoposide in the treatment of advanced gastric cancer: phase II study of the Southern Italy Oncology Group (GOIM)

Evaluation of microRNA-10b prognostic significance in a prospective cohort of breast cancer patients.

Evidence-based guidelines: Improving AGREEment on consistence evaluation

FOLFIRI regimen in advanced colorectal cancer: the experience of the Gruppo Oncologico dell'Italia Meridionale (GOIM).

FOLFIRI with or without celecoxib in advanced colorectal cancer: a randomized phase II study of the Gruppo Oncologico dell'Italia Meridionale (GOIM)

Frequent NRG1 fusions in Caucasian pulmonary mucinous adenocarcinoma predicted by Phospho-ErbB3 expression.

Frequent epigenetics inactivation of KEAP1 gene in non-small cell lung cancer

Gemcitabine and cisplatin for inoperable and/or metastatic biliary tree carcinomas: a multicenter phase II study of the Gruppo Oncologico dell'Italia Meridionale (GOIM).

Gene expression of somatostatin receptor subtypes SSTR2a, SSTR3 and SSTR5 in peripheral blood of neuroendocrine lung cancer affected patients.

Genomic instability and increased expression of BUB1B and MAD2L1 genes in ductal breast carcinoma

Heterogeneity of KRAS, NRAS, BRAF and PIK3CA mutations in metastatic colorectal cancer and potential effects on therapy in the CAPRI GOIM trial.

High RAD51 mRNA expression characterize estrogen receptor-positive/progesteron receptor-negative breast cancer and is associated with patient's outcome

High specificity of quantitative methylation-specific PCR analysis for MGMT promoter hypermethylation detection in gliomas

Irinotecan plus bolus/infusional 5-Fluorouracil and leucovorin in patients with pretreated advanced pancreatic carcinoma: a multicenter experience of the Gruppo Oncologico Italia Meridionale.

KRAS mutations and sensitivity to anti-EGFR monoclonal antibodies in metastatic colorectal carcinoma: an open issue

Liposomal-encapsulated doxorubicin plus cyclophosphamide as first-line therapy in metastatic breast cancer: a phase II multicentric study

MEN1 gene mutation with parathyroid carcinoma: first report of a familial case.

Management of Skin Reactions During Cetuximab Treatment in Association With Chemotherapy or Radiotherapy: Update of the Italian Expert Recommendations

Management of skin toxicity associated with cetuximab treatment in combination with chemotherapy or radiotherapy

MicroRNA co-expression networks exhibit increased complexity in pancreatic ductal compared to Vater's papilla adenocarcinoma.

Modeling interactions between Human Equilibrative Nucleoside Transporter-1 and other factors involved in the response to gemcitabine treatment to predict clinical outcomes in pancreatic ductal adenocarcinoma patients.

Molecular profiling in Italian patients with advanced non-small-cell lung cancer: An observational prospective study.

Molecularly targeted endocrine therapies for breast cancer.

Natural history of bone metastasis in colorectal cancer: final results of a large Italian bone metastases study

Natural history of malignant bone disease in gastric cancer: final results of a multicenter bone metastasis survey

Natural history of malignant bone disease in hepatocellular carcinoma: final results of a multicenter bone metastasis survey.

Natural history of malignant bone disease in renal cancer: final results of an Italian bone metastasis survey

New molecular targets in bone metastases.

Non-pegylated liposome-encapsulated doxorubicin citrate plus cyclophosphamide or vinorelbine in metastatic breast cancer not previously treated with chemotherapy:a multicenter phase III study

Novel association of MEN1 gene mutations with parathyroid carcinoma.

Optimized granulocyte colony-stimulating factor prophylaxis in adult cancer patients: from biological principles to clinical guidelines.

Pharmacokinetic drug evaluation of osimertinib for the treatment of non-small cell lung cancer.

Phase II study of panitumumab, oxaliplatin, 5-fluorouracil, and concurrent radiotherapy as preoperative treatment in high-risk locally advanced rectal cancer patients (StarPan/STAR-02 Study).

Phase III randomized trial of FOLFIRI versus FOLFOX4 in the treatment of advanced colorectal cancer: a multicenter study of the Gruppo Oncologico Dell'Italia Meridionale

Phase III trial comparing 3-6 months of adjuvant FOLFOX4/XELOX in stage II-III colon cancer: safety and compliance in the TOSCA trial

Phosphatidylinositol 3-kinase (PI3Kα)/AKT axis blockade with taselisib or ipatasertib enhances the efficacy of anti-microtubule drugs in human breast cancer cells.

Postchemotherapy residual masses in germ cell tumor patients: our experience